Abstract
The role of beta-blockers in older people (>75 years) with heart failure has been prospectively studied in the SENIORS study1 and retrospectively analysed from trials of metoprolol.2 In the recently published editorial accompanying the SENIORS study, it was concluded that it ‘is disappointing to see how infrequently elderly patients are prescribed these effective treatments’.3 As geriatricians, our concerns about the increased prevalence of adverse drug reactions in older people frequently impacts on our decision to prescribe medications.4 However, in the case of beta-blockers and heart failure, we also have concerns about the efficacy data. The …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
